32985495|t|Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.
32985495|a|BACKGROUND Existing research evidence indicates that breast cancer patients have different degrees of cognitive dysfunction after chemotherapy, and polymorphisms in 3 genes (catechol-O-methyltransferase, COMT; apolipoprotein E, APOE; and brain-derived neurotrophic factor, BDNF) have been associated with cognitive impairment. However, the role of these 3 gene polymorphisms in modulating cognitive impairment in breast cancer survivors with varying hormonal receptor expression is not clear at present. To explore the effects of genetic polymorphisms in BDNF, APOE, and COMT on the regulation of prospective memory impairments induced by chemotherapy in breast cancer patients with various expression levels of estrogen receptor (ER) and progesterone receptor (PR). MATERIAL AND METHODS A total of 232 patients with breast cancer (113 with ER-/PR- and 119 with ER+/PR+) were evaluated before and after chemotherapy for cognitive function, including prospective memory. Following previously published sequencing procedures, we assessed 6 single-nucleotide polymorphisms (SNPs), including BDNF (rs6265), APOE (rs429358, rs7412), and COMT (rs165599, rs4680, rs737865). RESULTS The patients showed poorer prospective memory scores after chemotherapy than before chemotherapy. Furthermore, the ER-/PR- group showed poorer event-based prospective memory (EBPM) scores than the ER+/PR+ group (z=-7.831, p<0.01) after chemotherapy. The patients with the COMT rs737865G/G genotype, compared with those with the A/A and A/G genotypes, showed a linear EBPM performance (ss=1.499, 95% confidence interval (CI)=1.017~2.211) and were less likely to have memory impairment. In contrast, APOE and BDNF polymorphisms did not influence cognitive performance. CONCLUSIONS The patterns of hormonal receptor expression may be related to prospective memory impairments induced by chemotherapy in breast cancer patients. Furthermore, the COMT polymorphism (rs737865) was linearly related to the extent of deficits in EBPM and may represent a potential genetic marker of risk for cognitive deficits triggered by chemotherapy in patients with breast cancer.
32985495	0	28	Catechol-O-Methyltransferase	Gene	1312
32985495	97	114	Memory Impairment	Disease	MESH:D008569
32985495	118	131	Breast Cancer	Disease	MESH:D001943
32985495	132	140	Patients	Species	9606
32985495	243	256	breast cancer	Disease	MESH:D001943
32985495	257	265	patients	Species	9606
32985495	292	313	cognitive dysfunction	Disease	MESH:D003072
32985495	364	392	catechol-O-methyltransferase	Gene	1312
32985495	394	398	COMT	Gene	1312
32985495	400	416	apolipoprotein E	Gene	348
32985495	418	422	APOE	Gene	348
32985495	428	461	brain-derived neurotrophic factor	Gene	627
32985495	463	467	BDNF	Gene	627
32985495	495	515	cognitive impairment	Disease	MESH:D003072
32985495	579	599	cognitive impairment	Disease	MESH:D003072
32985495	603	616	breast cancer	Disease	MESH:D001943
32985495	745	749	BDNF	Gene	627
32985495	751	755	APOE	Gene	348
32985495	761	765	COMT	Gene	1312
32985495	799	817	memory impairments	Disease	MESH:D008569
32985495	845	858	breast cancer	Disease	MESH:D001943
32985495	859	867	patients	Species	9606
32985495	902	919	estrogen receptor	Gene	2099
32985495	921	923	ER	Gene	2099
32985495	929	950	progesterone receptor	Gene	5241
32985495	952	954	PR	Gene	5241
32985495	993	1001	patients	Species	9606
32985495	1007	1020	breast cancer	Disease	MESH:D001943
32985495	1031	1033	ER	Gene	2099
32985495	1035	1037	PR	Gene	5241
32985495	1052	1054	ER	Gene	2099
32985495	1056	1058	PR	Gene	5241
32985495	1278	1282	BDNF	Gene	627
32985495	1284	1290	rs6265	SNP	tmVar:rs6265;VariantGroup:0;CorrespondingGene:627;RS#:6265;CorrespondingSpecies:9606
32985495	1293	1297	APOE	Gene	348
32985495	1299	1307	rs429358	SNP	tmVar:rs429358;VariantGroup:3;CorrespondingGene:348;RS#:429358;CorrespondingSpecies:9606
32985495	1309	1315	rs7412	SNP	tmVar:rs7412;VariantGroup:1;CorrespondingGene:348;RS#:7412;CorrespondingSpecies:9606
32985495	1322	1326	COMT	Gene	1312
32985495	1328	1336	rs165599	SNP	tmVar:rs165599;VariantGroup:2;CorrespondingGene:1312;RS#:165599;CorrespondingSpecies:9606
32985495	1338	1344	rs4680	SNP	tmVar:rs4680;VariantGroup:4;CorrespondingGene:1312;RS#:4680;CorrespondingSpecies:9606
32985495	1346	1354	rs737865	SNP	tmVar:rs737865;VariantGroup:5;CorrespondingGene:1312;RS#:737865;CorrespondingSpecies:9606
32985495	1369	1377	patients	Species	9606
32985495	1480	1482	ER	Gene	2099
32985495	1484	1486	PR	Gene	5241
32985495	1562	1564	ER	Gene	2099
32985495	1566	1568	PR	Gene	5241
32985495	1619	1627	patients	Species	9606
32985495	1637	1641	COMT	Gene	1312
32985495	1642	1650	rs737865	SNP	tmVar:rs737865;VariantGroup:5;CorrespondingGene:1312;RS#:737865;CorrespondingSpecies:9606
32985495	1650	1653	G/G	DNAMutation	tmVar:c|SUB|G||G;VariantGroup:6;CorrespondingGene:1312;CorrespondingSpecies:9606
32985495	1831	1848	memory impairment	Disease	MESH:D008569
32985495	1863	1867	APOE	Gene	348
32985495	1872	1876	BDNF	Gene	627
32985495	2019	2037	memory impairments	Disease	MESH:D008569
32985495	2065	2078	breast cancer	Disease	MESH:D001943
32985495	2079	2087	patients	Species	9606
32985495	2106	2110	COMT	Gene	1312
32985495	2125	2133	rs737865	SNP	tmVar:rs737865;VariantGroup:5;CorrespondingGene:1312;RS#:737865;CorrespondingSpecies:9606
32985495	2247	2265	cognitive deficits	Disease	MESH:D003072
32985495	2295	2303	patients	Species	9606
32985495	2309	2322	breast cancer	Disease	MESH:D001943
32985495	Negative_Correlation	MESH:D008569	RS#:737865;CorrespondingGene:1312
32985495	Association	1312	2099
32985495	Negative_Correlation	CorrespondingGene:1312;CorrespondingSpecies:9606;VariantGroup:6;tmVar:c	MESH:D008569
32985495	Association	MESH:D001943	RS#:737865;CorrespondingGene:1312
32985495	Association	MESH:D001943	RS#:6265;CorrespondingGene:627
32985495	Association	MESH:D001943	RS#:7412;CorrespondingGene:348
32985495	Association	MESH:D001943	RS#:165599;CorrespondingGene:1312
32985495	Association	MESH:D003072	627
32985495	Association	MESH:D001943	RS#:4680;CorrespondingGene:1312
32985495	Association	MESH:D003072	1312
32985495	Negative_Correlation	MESH:D008569	RS#:6265;CorrespondingGene:627
32985495	Association	MESH:D008569	1312
32985495	Association	MESH:D001943	2099
32985495	Association	MESH:D001943	627
32985495	Association	MESH:D001943	1312
32985495	Negative_Correlation	MESH:D008569	RS#:165599;CorrespondingGene:1312
32985495	Association	MESH:D001943	5241
32985495	Association	1312	5241
32985495	Association	MESH:D008569	1312
32985495	Association	MESH:D001943	1312
32985495	Association	MESH:D001943	627
32985495	Association	MESH:D001943	348
32985495	Association	MESH:D008569	627

